Gastrointestinal Diagnostics Market Size

Gastrointestinal Diagnostics Market Size

Gastrointestinal Diagnostics Market size was valued at USD 4.8 billion in 2023 and is expected to exhibit growth at a CAGR of 4.6% from 2024 and 2032. High market growth can be attributed to the ongoing advancements in diagnostic technologies, increasing prevalence of GI disorders, rising adoption of non-invasive diagnostic techniques, and growing healthcare expenditure, among other contributing factors.

To get key market trends

  Download Free Sample

Moreover, the rising incidence of GI disorders such as colorectal cancer, inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and others is a significant driver for GI diagnostics. For instance, as per the data published in Springer Nature, in 2023, inflammatory bowel disease (IBD) affects over 0.3% of the global population. Similarly, according to the NCBI, the national incidence of IBD was projected to be 29.9 per 100,000 in 2023. As the global population ages and lifestyles change, the prevalence of these conditions increases, necessitating more diagnostic procedures.
 

Furthermore, advances in diagnostic technologies have greatly improved the accuracy, sensitivity, and speed of GI diagnostic tests. Innovations such as endoscopic ultrasound (EUS), capsule endoscopy, virtual colonoscopy, and molecular diagnostics have enhanced clinicians' ability to detect and diagnose GI conditions at earlier stages, leading to better patient outcomes.
 

Gastrointestinal diagnostics refers to the array of medical procedures, tests, and techniques used to diagnose and evaluate disorders and diseases affecting the gastrointestinal (GI) tract, which includes the stomach, intestines, esophagus, liver, gallbladder, and pancreas.